West Pharmaceutical Services | WST - Despesas De Vendas E Administração

Preço das Ações
305.09
Mudança Diária
-1.07 -0.35%
Mensal
23.51%
Anual
42.20%
Q2 Previsão
299.61




Despesas De Vendas E Administração Alterar Data
Align Technology USD 441.68M 23.88M 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Cerus USD 19.33M 1.55M 2024-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Dentsply International USD 383M 28M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
ICU Medical USD 155.81M 3.04M 2025-12
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
J&J USD 6.03B 719M 2026-03
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Neogen USD 98.5M 9M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Quidel USD 194.4M 7.5M 2025-12
Repligen USD 74.36M 703K 2025-12
Rockwell Medical USD 4.04M 330K 2024-06
Solventum Corp USD 759M 15M 2025-12
STAAR Surgical USD 38.94M 20.44M 2025-12
Terumo JPY 105.26B 7.38B 2025-12
Utah Medical Products USD 2.61M 741K 2025-12
West Pharmaceutical Services USD 99.5M 7M 2026-03